Search results
Results From The WOW.Com Content Network
Before you buy stock in Viatris, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viatris wasn’t ...
Viatris (VTRS) beats on Q3 earnings and sales. The company raises the lower end of its annual revenue guidance. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...
Until recently, Viatris (NASDAQ:VTRS) was considered a value play among drug stocks. But after its recent earnings report, and announced sale of a key asset? The generic drug maker has been deemed ...
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn , a legacy division of Pfizer , on November 16, 2020.
For instance, if the record date is Sunday, then the ex-dividend date is the preceding Thursday, not Friday — assuming no intervening holidays. To be a stockholder on the record date, an investor must purchase the stock before the ex-dividend date in order to allow for the 1-trading day settlement of the stock purchase. If the investor ...
Viatris also reaffirmed its full-revenue revenue forecast to the range of $15.5 billion to $16 billion, compared to analysts' estimates of $15.60 billion. Excluding items, the company reported a ...
In 1976 the stock moved to the National Association of Securities Dealers Automated Quotations . Their final stock move was in 1986, when their stock became available for trade on the New York Stock Exchange under the ticker symbol MYL. Prior to the Viatris combination, the stock was traded on the NASDAQ.
You would be hard-pressed to find a pharmaceutical sector dividend that's as reliable as that of Bristol Myers Squibb's. The company has been doling out a shareholder distribution for 93 years.